NASDAQ:TCON   TRACON Pharmaceuticals, Inc.
Insiders are growing their longs.

2020-09-09 18:15:41
2020-09-04
TCON Opaleye Management Inc. 10% P - Purchase $3.38 +56,558 1,934,704 +3% +$190,902
2020-09-09 06:00:18
2020-09-04
TCON Theuer Charles Pres, CEO P - Purchase $2.58 +10,000 181,882 +6% +$25,750
DM
2020-09-03 17:15:20
2020-09-01
TCON Opaleye Management Inc. 10% P - Purchase $2.28 +159,800 1,878,146 +9% +$363,825
DM
2020-08-31 21:36:48
2020-08-27
TCON Opaleye Management Inc. 10% P - Purchase $1.74 +545,504 1,718,346 +47% +$950,378
2020-08-25 06:00:16
2020-08-21
TCON Theuer Charles Pres, CEO P - Purchase $1.56 +5,325 171,882 +3% +$8,307
2020-08-24 06:06:15
2020-08-20
TCON Theuer Charles Pres, CEO P - Purchase $1.58 +30,000 166,557 +22% +$47,400
M
2020-08-18 20:28:38
2020-08-14
TCON Theuer Charles Pres, CEO P - Purchase $1.63 +44,843 136,557 +49% +$73,021
M
2020-08-14 20:17:45
2020-08-12
TCON Theuer Charles Pres, CEO P - Purchase $1.73 +20,000 91,714 +28% +$34,500
2020-06-25 17:46:01
2020-06-24
TCON Theuer Charles Pres, CEO P - Purchase $1.90 +9,895 71,714 +16% +$18,801
DM
2020-06-16 17:24:05
2020-06-11
TCON Pelletier Saundra L Dir P - Purchase $2.04 +5,500 5,500 New +$11,209
2020-05-26 17:00:14
2020-05-22
TCON Theuer Charles Pres, CEO P - Purchase $1.90 +10,592 61,819 +21% +$20,119
2020-03-13 18:21:17
2020-03-13
TCON Theuer Charles Pres, CEO P - Purchase $1.13 +4,100 50,877 +9% +$4,624
M
2020-03-12 16:32:10
2020-03-11
TCON Theuer Charles Pres, CEO P - Purchase $1.43 +20,000 46,777 +75% +$28,639
2020-03-10 18:02:31
2020-03-10
TCON Theuer Charles Pres, CEO P - Purchase $1.87 +10,000 26,777 +60% +$18,691
2020-01-24 16:10:25
2020-01-23
TCON Wiggins Mark C Chief Business Officer P - Purchase $4.02 +5,000 5,000 New +$20,103
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.